CRISPR/Cas12a ribonucleoprotein mediated editing of tryptophan 2,3-dioxygenase of Spodoptera frugiperda
Transgenic Research · 2024
DOI: 10.1007/s11248-024-00406-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transgenic Research, 2024. Verfasst von Dhawane Yogi und 10 weiteren Autor:innen. Beteiligte Einrichtung: ICAR-Indian Institute of Horticultural Research, Bengaluru, Karnataka, 560089, India. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Spodoptera, Gene Editing, Ribonucleoproteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Centre for Agricultural Bioinformatics.
Abstract (Originalsprache)
In insect genome editing CRISPR/Cas9 is predominantly employed, while the potential of several classes of Cas enzymes such as Cas12a largely remain untested. As opposed to Cas9 which requires a GC-rich protospacer adjacent motif (PAM), Cas12a requires a T-rich PAM and causes staggered cleavage in the target DNA, opening possibilities for multiplexing. In this regard, the utility of Cas12a has been shown in only a few insect species such as fruit flies and the silkworm, but not in non-model insects such as the fall armyworm, Spodoptera frugiperda, a globally important invasive pest that defies most of the current management methods. In this regard, a more recent genetic biocontrol method known as the precision-guided sterile insect technique (pgSIT) has shown successful implementation in Drosophila melanogaster, with certain thematic adaptations required for application in agricultural pests. However, before the development of a controllable gene drive for a non-model species, it is important to validate the activity of Cas12a in that species. In the current study we have, for the first time, demonstrated the potential of Cas12a by editing an eye color gene, tryptophan 2,3-dioxygenase (TO) of S. frugiperda by microinjecting ribonucleoprotein complex into pre-blastoderm (G0) eggs. Analysis of G0 mutants revealed that all five mutants (two male and three female) exhibited distinct edits consisting of both deletion and insertion events. All five edits were further validated through in silico modeling to understand the changes at the protein level and further corroborate with the range of eye-color phenotypes observed in the present study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ICAR-Indian Institute of Horticultural Research, Bengaluru, Karnataka, 560089, India.
- Jain University, Bengaluru, Karnataka, 560069, India.
- ICAR-Indian Institute of Horticultural Research, Bengaluru, Karnataka, 560089, India. ashokg3s@gmail.com.
- Tamil Nadu Agricultural University, Coimbatore, Tamil Nadu, 641003, India. ashokg3s@gmail.com.
- University of Agricultural Sciences, Bengaluru, Karnataka, 560065, India.
- ICAR-Indian Agricultural Statistics Research Institute, New Delhi, 110012, India.
Förderung
- Centre for Agricultural Bioinformatics
Zitieren
APA
Yogi, D., Ashok, K., Anu, C. N., Shashikala, T., Pradeep, C., Bhargava, C. N., Parvathy, M. S., Jithesh, M. N., Manamohan, M., Jha, G. K., & Asokan, R. (2024). CRISPR/Cas12a ribonucleoprotein mediated editing of tryptophan 2,3-dioxygenase of Spodoptera frugiperda. Transgenic Research. https://doi.org/10.1007/s11248-024-00406-9
Vancouver
Yogi D, Ashok K, Anu CN, Shashikala T, Pradeep C, Bhargava CN, et al. CRISPR/Cas12a ribonucleoprotein mediated editing of tryptophan 2,3-dioxygenase of Spodoptera frugiperda. Transgenic Research. 2024. doi:10.1007/s11248-024-00406-9
BibTeX
@article{Yogi2024,
author = {Yogi, Dhawane and Ashok, Karuppannasamy and Anu, Cholenahalli Narayanappa and Shashikala, Thalooru and Pradeep, Chalapathy and Bhargava, Chikmagalur Nagaraja and Parvathy, Madhusoodanan Sujatha and Jithesh, M N and Manamohan, Maligeppagol and Jha, Girish Kumar and Asokan, Ramasamy},
title = {CRISPR/Cas12a ribonucleoprotein mediated editing of tryptophan 2,3-dioxygenase of Spodoptera frugiperda},
journal = {Transgenic Research},
year = {2024},
doi = {10.1007/s11248-024-00406-9}
}
EUVIMED